Upload
phamcong
View
220
Download
0
Embed Size (px)
Citation preview
REFERENCES
REFRENCES
9. REFERENCES
Abarca-Hidemann K, Friederichs S, Klamp T, Boehm U, Guethlein LA and
Ortmann B (2002) Regulation of the expression of mouse TAP-associated
glycoprotein (tapasin) by cytokines. Immunol. Lett., 83: 197-207.
Abdollahi A, Lord KA, Roffman-Liebermann B and Liebermann D (1991) IRF-1
is a myeloid differentiation primary response gene induced by IL-6 and leukemia
inhibitory factor: role in growth inhibition. Cell growth differ., 2: 401-407.
Akira S, Uematsu S and Takeuchi 0 (2006) Pathogen recognition and innate
immunity. Cell. 124: 783-801
Au WC, Moore PA, LaFleur DW, Tombal B, and Pitha PM (1998)
Characterization of the interferon regulatory factor-7, and its potential role in the
transcription activation of interferon A genes. J. Bioi. Chern. 273, 29210.
Au WC, Moore PA, Lowther W, Juang YT, and Pitha PM (1995) Identification of
a member of the interferon regulatory factor family that binds to the interferon
stimulated response element and activates expression of interferon- induced genes.
Proc. Natl. Acad. Sci. USA 92, 11657.
Au WC, Yeow WS and Pitha PM (2001) Analysis of functional domains of
interferon regulatory factor 7 and its association with IRF-3. Virology 280 (2):
273-287
Aziz, F., van Wijnen, A. J., Stein, J. L. and Stein, G. S. (1998). HiNF-D (CDP
cut/CDC2/cyclin A/pRB-complex) influences the timing of IRF-2-dependent cell
cycle activation of human histone H4 gene transcription at the G liS phase
transition. J Cell Physiol. 177(3):453-464.
Aziz, F., van Wijnen, A. J., Vaughan, P. S., Wu, S., Shakoori, A. R., Lian, J. B.,
Soprano, K. J., Stein, J. L. and Stein, G. S. (1998). The integrated activities of
IRF-2 (HiNF-M), CDP/cut (HiNF-D) and H4TF-2 (HiNF-P) regulate transcription
101
REFRENCES
of a cell cycle controlled human histone H4 gene: mechanistic differences
between distinct H4 genes. Mol Bioi Rep. 25(1):1-12.
Barnes B, and Pitha M (2002) On the role of IRF in host defense. JICR., 22, 59-71
Battistini A, Marsili G, Sgarbanti M, Ensoli B, Hiscott J. (2002). IRF
regulation of HIV -1 long terminal repeat activity. J. Inteiferon Cytokine Res.
22(1):27-37. Review.
Behera AK, Kumar M, Lockey RF, Mohapatra SS. (2002). 2'-5' Oligoadenylate
synthetase plays a critical role in interferon-gamma inhibition of respiratory
syncytial virus infection of human epithelial cells. J. Bioi. Chem.
277(28):25601-8.
Birnbaum, M. J., Zundert, B., Vaughan ,P. S., Whitmarsh, A. J., van, Wijnen, A.
J., Davis, R. J., Stein, G. S. and Stein, J. L. (1997). Phosphorylation of the
oncogenic transcription factor interferon regulatory factor 2 (IRF2) in vitro and in
vivo. J Cell Biochem. 66(2): 175-183.
Blanco JC, Contursi C, Salkowski CA, DeWitt DL, Ozato K, Vogel SN.
(2000). Jun.Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon
gamma-dependent cyclooxygenase 2 expression. J. Exp. Med. 191(12):2131-
44.
Blanco, C., Salkowski, C. A., DeWitt, D. L., Ozato. and Vogel, K. (2000).
Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma
dependent cyclooxygenase 2 expression. J. Exp. Med. 191(12):2131-2144.
Bovolenta, C., Driggers, P, H., Marks, M, S., Medin, J, A., Politis, A,D., Vogel, S,
N., Levy, D, E., Sakaguchi, K.,Appella, E. and Coligan, J, E.(1994) Molecular
interactions between interferon consensus sequence binding protein and members
of the interferon regulatory factor family. Proc. Natl.Acad. Sci. U S A.
91(11):5046-5050.
REFRENCES
Burysek L, Pitha PM. (2001) Mar.Latently expressed human herpesvirus 8-
encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated
protein kinase. J. Virol.;15(5):2345-52.
Burysek L, Yeow WS, Lubyova B, Kellum M, Schafer SL, Huang YQ, Pitha
PM. (1999). Sep. Functional analysis of human herpesvirus 8-encoded viral
interferon regulatory factor 1 and its association with cellular interferon
regulatory factors and p300. J. Virol. 73(9): 7334-42.
Burysek L, Yeow WS, Pitha PM. (1999). Unique properties of a second human
herpesvirus 8-encoded interferon regulatory factor (viRF-2). J. Hum.
Virol. ;2( 1 ): 19-32.
Chen L, Glover JNM, Hogan PG, Rao A and Harrison SC (1998) Structure of
the DNA binding domains from NFAT, Fos and Jun bound specifically to
DNA. Nature. 392: 42-48.
Childs KS and Goodboum S. (2003) Identification of novel co-repressor
molecules for Interferon Regulatory Factor-2. Nucleic Acids Res. 31(12): 3016-
26.
Choi Y, Johnson GA, Burghardt RC, Berghman LR, Joyce MM, Taylor KM,
Stewart MD, Bazer FW, Spencer TE. (2001). Interferon regulatory factor-two
restricts expression of interferon-stimulated genes to the endometrial stroma
and glandular epithelium of the ovine uterus. Biol Reprod.; 65(4):1038-49.
Chow WA, Fang JJ, Yee JK.(2000). The IFN regulatory factor family
participates in regulation of Fas ligand gene expression in T cells. J. Immunol.
164(7):3512-8.
Coccia EM, Del Russo N, Stellacci E, Orsatti R, Benedetti E, Marziali
G,Hiscott J, Battistini A.(1999). Activation and repression of the 2'-5'A
synthetase and p21 gene promoters by IRF-1 and IRF-2. Oncogene.
18(12):2129-37.
103
REFRENCES
Coccia EM, Stellacci E, Valtieri M, Masella B, Feccia T, Marziali G, Hiscott J,
Testa U, Peschle C, Battistini A.(2001). Ectopic expression of interferon
regulatory factor-1 potentiates granulocytic differentiation. Biochem J.
360(2):285-94.
Cohen Land Hiscott J (1992) Characterization of TH3, an induction-specific
protein interacting with the interferon beta promoter. Virology. 191(2): 589-99.
Cuesta N, Salkowski CA, Thomas KE, Vogel SN. (2003). Regulation of
lipopolysaccharide sensitivity by IFN regulatory factor-2. J. Immunol. 170(11):
5739-47.
Cunningham C, Barnard S, Blackboum DJ, and Davison AJ (2003)
Transcription mapping of Human herpes virus 8 genes encoding viral
interferon regulatory factors. J. Gen. Virol., 84: 1471-1483.
Darnell, J. E., Kerr, I. M. and Stark G. R. (1994). JAK-STAT pathways and
transcriptional activation in response to IFNs and other extracellular singling
proteins. Science 264:1415-1421.
Doherty GM, Boucher L, Sorenson K, Lowney J. (2001). Interferon regulatory
factor expression in human breast cancer. Ann Surg. 233(5): 623-9.
Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM and Ozato K (1995)
NFKB and IRF-1 physically interact and synergistically induce maJor
histocompatibility class I gene expression. 1./.C.R., 15:1037-1047.
Dror 0, Nussinov Rand Wolfson HJ (2006) The ART web server for aligning
RNA tertiary structures. Nucleic Acid Res., 34: W412-W415.
Duncan GS, Mittrucker HW, Kagi D, Matsuyama T and Mak TW (1996) The
transcription factor IRF-1 is essential for NK cell function in vivo. J.EXP.
Med., 184: 2043-2048.
1011
REFRENCES
Du MX, Sotero-Esteva WD and Taylor MW (2000) Analysis of transcription
factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma. J
Inteiferon Cytokine Res. 20(2): 133-42.
Elser B, Lohoff M, Kock S, Giaisi M, Kirchhoff S, Krammer PH, Li-Weber M.
(2002). dec.IFN-gamma represses IL-4 expression via IRF-1 and IRF-2.
Immunity. 17(6):703-12.
Escalante, C. R.,Yie, J., Aggarwal, A. K. and Thonos, D. (1998). Structure of IRF-
1 with bound DNA reveals determinants of IFN regulation. Nature. 391:103-106.
Eisenbeis CF, singh H and storb U (1995) Pip, a novel IRF family member, is a
lymphoid specific , PU.1 -dependent transcriptional activator. Genes Dev., 9:
1377-1387.
Falvo JV, Parekh BS, LinCH, Fraenkel E, Maniatis T. (2000). Assembly of a
functional beta interferon enhanceosome is dependent on ATF-2-c-jun
heterodimer orientation. Mol Cell Bioi. 20(13):4814-25.
Fan, C, M., and Maniatis, T.(1989) Two different virus inducible elements are
required for human IFN gene regulation. EMBO J. 8:101-110.
Fehr T, Schoedon G, Odermatt B, Holtschke T, Schneemann M, Bachmann MF,
Mak TW, Horak I and Zinkemagel RM (1997) Crucial role of interferon
consensus sequence binding protein, but neither of interferon regulatory factor 1
nor of nitric oxide synthesis for protection against murine listeriosis. J. Exp. Med.
185: 921-31
Feng X, Petraglia AL, Chen M, Byskosh PV, Boos MD, Reder AT. (2002).
Low expression of interferon-stimulated genes in active multiple sclerosis
islinked to subnormal phosphorylation of STAT!. J Neuroimmunol. 129(1-2):
205-15.
]()"
REFRENCES
Flowers CC, Flowers SP and Nabel GJ (1998) Kaposi's Sarcoma-associated
herpes virus viral IRF confers resistance to the antiproliferative effect of
interferon alpha. Mol. Med. 4: 402-4012
Fuji, Y.1999.Crystal Structure of an IRF-DNA Complex Reveals Novel DNA
Recognition and Cooperative Binding to a Tandem Repeat of Core Sequence,
EMBO J., 18, pp.5028 .
Furui J, Uegaki K, Yamazaki T, Shirakawa M, Swindells MB, Harada H,
Taniguchi T, Kyogoku Y. (1998) Solut!on structure of the IRF-2 DNA-binding
domain: a novel subgroup of the winged helix-tum-helix family. Structure. 6(4):
491-500.
Fujii Y, Shimizu T, Kusumoto M, Kyogoku Y, Taniguchi T, Hakoshima T.
(1999). Crystal structure of an IRF-DNA complex reveals novel DNA
recognition and cooperative binding to a tandem repeat of core sequences.
EMBO J. 18(18): 5028-41.
Fujii, Y., Shimizu, T., Kusumoto, M., Kyogoku, Y., Taniguchi, T. and
Hakoshima, T. (1999) Crystal structure of an IRF-DNA complex reveals novel
DNA recognition and cooperative binding to a tandem repeat of core sequences.
EMBO J 18(18):5028-5041.
Fujita T, Sakakibara J, Sudo Y, Miyamoto M, Kimura Y and Taniguchi T (1998)
Evidence of a nuclear factor(s), IRF-1, mediating induction and silencing
properties to human IFN-~ gene regulatory elements. EMBO J., 7: 3397-4505.
Fujita, T. Kimura, Y., Miyamoto, M. and Taniguchi, T. (1989) Induction of
endogenous IFNa and IFN~ genes by a regulatory transcription factors IRF-1.
Nature. 337:270-272.
106
REFRENCES
Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y and Moore PS (1997)
KSHV ORF K9 (viRF) is an oncogene which inhibits the interferon signaling
pathway. Oncogene 15: 1979-1985.
Glover JNM and Harrison SC (1995) Crystal structure of the heterodimeric bZIP
transcription factor c-Fos-c-Jun bound to DNA. Nature, 373:257-261
Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U,
Boss JM, Blanck G. (2001). Varying functions of specific major
histocompatibility class II transactivator promoter III and IV elements in
melanoma cell lines. Cell Growth Differentiation. 12(6): 327-35.
Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J, and Schreiber
RD (1995) Stat recruitment by tyrosine phosphorylated cytokine receptors: an
ordered reversible affinity-driven process. Immunity 2: 677-87
Grieder FB, Vogel SN (1999) Role of interferon and interferon regulatory
factors in early protection against Venezuelan equine encephalitis virus
infection. Virology. 257(1): 106-18.
Guillemard E, Varano B, Belardelli F, Quero AM, Gessani S. (1999).
Inhibitory activity of constitutive nitric oxide on the expression of alpha/beta
interferon genes in murine peritoneal macrophages. J Viral. 73(9):7328-33.
Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T
and Taniguchi T. (1989) Structurally similar but functionally distinct factors, IRF-
1 and IRF-2, bind to the same regulatory elements of IFN and /FN-inducible
genes. Cell. 58( 4 ): 729-739.
Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T and Taniguchi T
( 1990) Absence of type IFN system in EC cells: transcriptional activator, (IRF-1)
and repressor (IRF-2) genes are developmentally regulated. Cell, 63: 903-913.
107
REFRENCES
Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M,
Taniguchi T. (1993) Anti-oncogenic and oncogenic potentials of interferon
regulatory factors-1 and -2.Science. 259( 5097):971-97 4.
Harada H, Takahashi E, ltoh S, Harada K, Hori TA and Taniguchi T (1994)
Structure and regulation of the human IRF-1 and IRF-2 genes: implications for a
gene network in the IFN system. Mol. Cell. Biol., 14: 1500-9
Harada H, Matsumoto, Sato M, Kashiwazaki Y, Kimura T, Kitagawa M, Yokochi
T, Sok-PinTan R, Takasugi T, Kadokawa Y, Schindler C, Schreiber RD, Noguchi
S, and Taniguchi T (1996) Regulation of IFN-a/a genes: evidence for a dual
function of the transcription factor complex ISGF3 in the production and action of
IFN-a/a. Genes cell, 1: 115-124.
Harada H, Taniguchi T and Tanaka N (1998) The role of interferon regulatory
factors in the interferon system and cell growth control. Biochimie. 80(8-9): 641-
50. Review.
Hida S, Ogasawara K, Sato K, Abe M, Takayanagi H, Yokochi T, Sato T,
Hirose S, Shirai T, Taki S, Taniguchi T. (2000). CD8(+) T cell-mediated skin
disease in mice lacking IRF-2, the transcriptional attenuator of interferon
alpha/beta signaling./mmunity. 13(5): na643-55.
Hiscott J, Pitha P, Genin P, Nguyen H, Heylbroeck C, Mamane Y, Algarte M, Lin
R. 1999.Triggering the interferon response: the role of IRF-3 transcription factor.
J. Interferon Cytokine Res., 19: 1-14.
Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, Rousenbauer F, Lou J,
Knobeloch KP, Gabriele L, waring JF, Bachmann MF, Zinkemagel RM, Morse
HC 3rd, Ozato K and Horak (1996) Immunodeficiency and chronic myelogenous
leukiemia-like syndrome in mice with a targeted mutation of the ICSBP gene.
Cell. 87: 307-317.
108
REFRENCES
Honda K, Mizutani T and Taniguchi T (2004) Negative regulation of IFN
alpha/beta signaling by IFN regulatory factor-2 for homeostatic development of
dendritic cells. PNAS USA., 101, 2416-24121.
Honda K, Yanai H, Negishi H, Asagiri M, Sato T, Mizutani T, Shimada N, Ohba
Y, Takoka A, Yoshida N and Tanighuchi T (2005) IRF-7 is the master regulator
of type -1 interferon -dependent immune responses. Nature, 434, 772-777.
Honda K, Takaoka A and Taniguchi T (2006) Type I Interferon gene induction by
IRF family of transcription factors. Immunity 25: 349-360.
Hu G and Barnes BJ (2006) IRF-5-regulated pathways as a target for colorectal
cancer therapeutics. Expert Rev. Anticancer Ther., 6: 775-784.
Huth JR, Bewely CA, Nissen MS, Evans JNS, Reeves R, Gronenbom AM and
Clore GM (1997) The solution structure of an HMG-I(Y)-DNA complex defines a
new architectural minor groove binding motif. Nature struct. Bioi., 4: 657-665.
lhle JN and Kerr IM ( 1995) J aks and Stats in signaling by the cytokine receptor
superfamily. Trends Genet., 11: 69-74.
Improta T, Schindler C, Horvath CM, Kerr IM, Stark GR, and Jr. Darnel JE
(1994) Transcription factor ISGF3 formation requires phosphorylated Sat91
protein, but Stat 113 protein is phosphorylated independently of Stat91 protein.
PNAS, USA., 91: 4776-4780
Ingraham CR, Kinoshita A, Kondo S, Yang B, Sajan S, Trout KJ, Malik MI,
.Dunnwald M, Goudy S.L., Lovett M, Murray JC and Schutte BC (2006)
Abnormal skin, limb, and craniofacial morphogenesis in mice deficient for IRF-6.
Nat. Genet., 38: 1335-1340.
Itoh, S., Harada, H., Fujita, T., Mimura, T. and Taniguchi, T. (1989) Nucleotide,
Protein Sequence of a eDNA coding for human IRF-2. Nucleic Acids Res.
17(20):8372.
!(\(\
REFRENCES
Iwase S, Furukawa Y, Kikuchi J, Saito S, Nakamura M, Nakayama R,
Horiguchi-Yamada J, Yamada H. (1999). Defective binding of IRFs to the
initiator element of interleuk:in-1 beta-converting enzyme (ICE) promoter in an
interferon-resistant Daudi sub line. FEBS Lett. 450(3): 263-7.
Jarosinski KW and Massa PT (2002) IRF-1 is required for IFN-y-induced
MHC class I genes in astrocytes. J. Neuroimmunol., 122: 74-84.
Jesse, T. L., Lachance, Rand Ladermann, M. F.(1998) IRF-2 is a transcriptional
activator inmuscle where it regulates expression of Vascular and Cell Adhesion
Molecule-1(VCAM-1). J.Cell.Biol140:1265-76.
Jenner RG, Alba MM, Boshoff C and P. Kellam (2001) Kaposi's sarcoma
associated herpes virus latent and lytic gene expression as revealed by DNA
arrays. J. Virol., 75:891-902
Johnson GA, Joyce MM, Yankey SJ, Hansen TR, Ott TL. (2002). The
Interferon Stimulated Genes (ISG) 17 and Mx have different temporal and
spatial expression in the ovine uterus suggesting more complex regulation of
the Mx gene. J Endocrinol. 174(2):R7-R11.
Juang YT, Lowther W, Kellum M, Au WC, Lin R, Hiscott J, Pitha
PM.1998.Primary activation of IFNa and IFN§ gene expression by IRF-3. Proc.
Nat. Acad. Sci. 95: 9837-9842.
Juang, Y.-T., Lowther, W., Kellum, M., Au, W.-C., Lin, R., Hiscott, J., and Pitha,
P.M. 1998.Primary activation of interferon A and interferon B gene transcription
by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95, 9837.
Kamijo R, Harada H and Matamyame, T (1994) Requirement for transcription
factor IRF-1 in Nitric oxide synthetase induction in Macrophages. Science
263:1612-1615.
110
REFRENCES
Keller AD and Maniatis T ( 1991) Identification and characterization of a novel
repressor of ~-IFN gene expression. Genes Dev., 5: 868-879.
Kim EJ, Lee JM, Narnkoong SE, Urn SJ, Park JS. (2002). Interferon regulatory
factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma
cells. J. Cell. Biochern. 85(2): 369-80.
Kim T, Kim TY, Song YH, Min I.M, Yim J, and Kim TK (1999) Activation of
IRF3 in response to DNA damaging agents. J. Bioi. Chern. 274: 30686.
Kim EJ, Park CH, Park JS and Urn SJ (2003) Functional dissection of the
transactivation domain of IRF-1. B.B.R. C., 304:253-259
Kraus T A, Lau JF, Parisien JP and Horvath CM (2003) A hybrid IRF9-ST A T2
protein recapitulates interferon-stimulated gene expression and antiviral response.
J. Biol. Chern., 278: 13033-13038.
Kimura T, Nakayama K, Penninger J, Kitagawa M, Harada H, Matsuyama T,
Tanka N, Kamijo Ret. a/.,(1994) Involvement of the IRF-1 transcription factor in
antiviral responses to interferons. Science, 264, 1921-1924.
Kimura T, Kadokawa Y, Harada H, Matsumoto M, Sato M, Kashiwazaki Y,
Tarutani M, Tan RS, Tkasugi T, Matsuyama T, Mak TW, Noguchi S and
Taniguchi T (1996) Essential and non-redundant role of p48(1SFG3y) and IRF-1
in both type I and type II interferon responses, as revealed by gene targeting
studies. Gene Cells, 1: 115-124.
Kirchhoff S, Oumard A, Nourbakhsh M, Levi BZ, Hauser H. (2000). Interplay
between repressing and activating domains defines the transcriptional activity
of IRF-1. Eur J Biochern. 267(23): 6753-61.
Ill
REFRENCES
Kyte J and Doolittle RF (1992) A simple method for displaying the
hydropathic character of a protein. 1.Mol. Biol., 157: 105-132
Ko J, Gendron-Fitzpatrick A, Splitter GA. (2002). Susceptibility of IFN
regulatory factor-1 and IFN consensus sequence binding protein-deficient mice
to brucellosis. 1 Immunol.168(5):2433-40.
Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y,
Howard E, de Lima RL, et. al., (2002) Mutations in IRF6 cause Van der
Woude and popliteal pterygium syndromes. Nat. Genet., 32: 285-289.
Koenig Merediz SA, Schmidt M, Hoppe GJ, Alfken J, Meraro D, Levi BZ,
Neubauer A, Wittig B. (2000). Cloning of an interferon regulatory factor 2
isoform with different regulatory ability. Nucleic Acids Res. 28(21): 4219-24.
Kroger, A., Koster, M., Schroeder, K., and Mueller, P.P.(2002) Activities of IRF-
1 . 1./.C.R. 22:5-14.
Kroger A, OrtmannD, Krohne TU, Mohr L, Blum HE, Hauser and Geissler M
(2001) Growth suppression of the hepatocellular carcinoma cell line Hepal-6 by
an activable IRF-1 in mice. Cancer Res., 61, 2601-2617.
Kuo TC and Calame KL (2004) B lymphocyte-induced maturation protein
(Blimp )-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same
regulatory sites. 1 Immunol., 73(9): 5556-63.
Lechleitner, S., Gille, J., Johnson, D.R. and Petzelbauer, P. (1998) Interferon
enhances tumor necrosis factor-induced vascular cell adhesion molecule 1
(CD106) expression in human endothelial cells by an interferon-related factor 1-
dependent pathway. 1 Exp Med. 187(12):2023-2030.
Lee PT, Holt PG, McWilliam AS. (2001). Failure of MHC class II expression
in neonatal alveolar macrophages: potential role of class II transactivator. Eur 1
Immunol. 31(8): 2347-56.
112
REFRENCES
Li W, Nagineni CN, Efiok B, Chepelinsky AB, Egwuagu CE. (1999).
Interferon regulatory transcription factors are constitutively expressed and
spatially regulated in the mouse lens. Dev Bioi. 210(1): 44-55.
Li W, Nagineni CN, Hooks JJ, Chepelinsky AB, Egwuagu CE. (1999).
Interferon-gamma signaling in human retinal pigment epithelial cells mediated
by ST AT1, ICSBP, and IRF-1 transcription factors. Invest Ophthalmol Vis Sci.
40(5): 976-82.
Lin R, Heylbroeck C, Genin P, Pitha PM, Hiscott J (1999) Essential role of IRF-3
in direct activation of RANT'SS gene transcription. Mol Cell Bioi. 19: 959-966.
Lin R, Heylbroeck C, Pitha PM, Hiscott J (1998) Virus dependent
phosphorylation of the IRF-3 transcription factor regulates nuclear translocation,
transactivation potential and proteasome-mediated degradation. Mol. Cell. Bioi.
18: 2986-2996.
Lin RT, Mamane Y, Hiscott J (1999) Structural and functional analysis of
interferonregulatory factor 3: localization of the transactivation and autoinhibitory
domains Molecular and cellular biology 19(4): 2465-2474
Lin R. and Hiscott J ( 1999) A role of casein kinase II phosphorylation in the
regulation of IRF-1 transcriptional activity. Mol.Cell.Biochem.191: 169-180.
Liu J, Guan X, Tamura T, Ozato K and MaX (2004) Synergistic activation of IL-
12p35 gene transcription by IRF-1 and ICSBP. 1. Bioi. Chem., 279: 55609-55617.
Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M and
Mak TW(1997) Interferon regulatory factor-1 is required for aT helper 1 immune
response in vivo. Immunity 6:681- 89.
Lohoff, M., Duncan, G. S., Ferrick, D., Mittrucker, H, W., Bischof, S., Prechtl, S.,
Rollinghoff, M., Schmitt, E., Pahl, A. and Mak, T. W. (2000).
113
REFRENCES
Deficiency in the transcription factor interferon regulatory factor (IRF)-2
leads to severely compromised development of natural killer and T helper
type 1 cells. J Exp Med. 192(3):325-336
Lowney JK, Boucher LD, Swanson PE, Doherty GM. (1999). Interferon
regulatory factor-1 and -2 expression in human melanoma specimens. Ann Surg
Oncol. 6(6):604-8.
Lu, R., and Pitha, P.M. (2001) Monocyte differentiation to macrophase requires
interferon regulatory factor 7, J. Bioi. Chern., 276.
Lubyova B, Kellum MJ, Frisancho AJ and Pitha PM (2004) Kaposi's sarcoma
associated herpesvirus-encodedviRF-3 stimulates the transcriptional activity of
cellular IRF-3and IRF-7. J. Bioi. Chern., 279: 7643-7654
Lubyova B and Pitha PM (2000) Characterization of a novel human herpes virus
8-encoded protein, viRF-3, that shows homology to viral and cellular IRFs. J.
Virol., 74: 8194-8201.
Mancl ME, HuG, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald-Bocarsly
P, Pitha PM, Pinder K and Barnes BJ (2005) Two discrete promoters regulate the
alternatively spliced human IRF-5 isoforms. Multiple isoforms with distinct cell
type-specific expression, localization, regulation and function. J. Bioi. Chern.,
280: 21078-21090.
Meraro D, Hashmueli S, Koren B, Azriel A, Oumard A, Krichhoff S, Hauser H,
Nagulapalli S, Atchison ML and Levi BZ (1999) Protein -protein and DNA
protein interactions affect the activity of lymphoid specific IFN Regulatory
Factors. J. Irnrnuno/.163: 6468-6478.
Meraro D, Gleit-Kielmanowicz M, Hauser H, and Levi BZ (2002) IFN stimulated
gene 15 is synergistically activated through interactions between the
myelocyte/lymphocyte-specific transcription factors, PU .1, IRF-8/ICSBP, and
114
REFRENCES
IRF-4: characterization of a new subtype of IFN-stimulated response element. J.
Immunol., 168: 6224-6231
Mittrucker HW, Matsuyama T, Grossman A, Kudig TM, Potter J, Shahinian A,
Wakeham A, Patterson B, Ohashi PS and Mak TW (1997) Requirement of
transcription factor LSIRF/IRF-4 for mature B and T lymphocyte function.
Science, 275, 540-543.
Mamane, Y., Heylbroeck, C., Genin, P., Algarte, M., Servant, M. 1., DeLuca, C.,
K won, H. and Lin, R. (1999) Hiscott J .Interferon regulatory factors: the next
generation. Gene. 237(1):1-14. Review.
MacDonald NJ, Kuhl D, Maguire D, Naf D, Gallant P, Goswamy A, HugH,
Bueler H, Chatruvedi M, Fuente JDL, Ruffner, H, Meyer F and weissmann C
(1990) Different pathways Mediate Virus Inducibility of the Human IFN-a1 and
IFN-~ genes. Cell. 60: 767-779.
Manzella L, Gualdi R, Perrotti D, Nicolaides NC, Girlando G, Giuffrida MA,
Messina A, Calabretta B. (2000). The interferon regulatory factors 1 and 2 bind
to a segment of the human c-myb first intron: possible role in the regulation of
c-myb expression. Exp Cell Res. 256(1): 248-56.
Marecki S, Atichson ML and Fenton MJ (1999) Differential expression and
Distinct functions of IRF-4 and ICSBP in macrophages. J. lmmunol., 163:
2713-2722
Marecki S, Riendeau CJ, Liang MD, Fenton MJ. (2001). PU.l and multiple
IFN regulatory factor proteins synergize to mediate transcriptional activation of
the human IL-l beta gene. 1 Immunol. 166(11): 6829-38.
Marie I, Durbin JE and Levy DE (1998) Differential viral induction of distinct
IFN-a genes by positive feedback through IRF-7. EMBO 1., 17: 6660-6669
115
REFRENCES
Massa PT, Whitney LW, Wu C, Ropka SL, Jarosinski KW. (1999). A
mechanism for selective induction of 2'-5' oligoadenylatesynthetase,anti-viral
state, but not MHC class I genes by interferon-beta in neurons. J Neurovirol.
5(2): 161-71.
Masumi A, Wang IM, Lefebvre B, Yang XJ, Nakatani Y and Ozato K (1999)
The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF
family that confers enhanced interferon responsiveness. Mol Cell Bioi. 19(3):
1810-20.
Masumi A, Ozato K. (2001). Coactivator p300 acetylates the interferon
regulatory factor-2 in U937 cells following phorbol ester treatment. J Bioi
Chern. 276(24): 20973-80. Epub.
Masumi A, Yamakawa Y, Fukazawa H, Ozato K, Komuro K. (2003).
Interferon regulatory factor-2 regulates cell growth through its acetylation .. J.
Bioi Chern. [Epub ahead of print]
Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N,
Kudig TM, Amakawa R, Kishihara K, Wakeham A et. al. (1993) Targeted
disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction
and abberent lymphocyte development. Cell, 75, 83-97.
Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan
DH, Riley JK, Greenlund AC, Campbell D and Schreiber RD (1996)
Targeted disruption of the Stat1 gene results in compromised innate immunity
to viral disease. Cell, 84: 431-42
Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata
T and Taniguchi T (1988) Regulated expression of a gene encoding a nuclear
factor, IRF-1, that specifically binds to IFN-~ gene regulatory elements. Cell,
54: 903-913.
116
REFRENCES
Moore PS and Chang Y (1998) Antiviral activity of tumor-suppressor
pathways: clues from molecular piracy by KSHV. Trends Genet., 14: 144-150.
Mostowska A, Wojcicki P, Kobus K, and Trzeciak WH (2005) Gene symbol:
IRF-6. Disease: VanderWoude syndrome. Hum. Genet., 116: 534
Mori T, Anazawa Y, Liizumi M, Fukuda S, Nakamura Y and Arakawa H
(2002) Identification of the IRF-5 as a direct target for p53. Oncogene 21:
2914-2918.
Munshi N, Yie Y, Merika M, Senger K, Lomvardas S, Agalioti T and Thanos
D (1999) The IFN-13 enhancer: a paradigm for understanding activation and
repression of individual gene expression. Cold Spring Harb. Symp. Quant.
Bioi. 64, 149-159.
Munshi N, Agalioti T, Lomvardas S, Merika M, ChenG and Thanos D (2001).
Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 293,
1133-1136.
Nehyba J, Hrdlickova R, Burnside J and Bose HR Jr. (2002) A novel IRF, IRF-
10, has a unique role in immune defense and is induced by the V -rei
oncoprotein. Mol. Cell. Boil., 22:3942-3957
Nguyen H., Hiscott J. and Pitha P.M.( 1997) The growing family of interferon
regulatory factors. Cytokine Growth Factor Rev. 8(4):293-312. Review.
Nishio Y., Noguchi E., Ito S., Ichikawa E., Umebayashi Y., Otsuka F. and
Arinami T. (2001) Mutation and association analysis of the interferon regulatory
factor 2 gene (IRF2) with atopic dermatitis. 1 Hum Genet. 46( 11 ): 664-7.
Nishihira J (1993) Identification and chararcterization of hydrophobic ligand
binding region in glutathione S-transferase P. Hokkaido IgakuZasshi [article in
Japanese] 68: 54-64.
REFRENCES
Nonkwelo C, Ruf IK, and sample J (1997) Interferon dependent and induced
regulation of Epstein-Barr Virus EBNA-1gene transcription in Burkitt lymphoma.
J. Virol. 71: 6887-6897.
Nonkwelo, C., Ruf, I. K. and Sample, J. (1997) Interferon-independent and
induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt
lymphoma. J Virol.71(9):6887-97.
Oberg K. (2000). Interferon in the management of neuroendocrine GEP-tumors: a
review. Digestion.;62 Suppl1:92-7. Review.
Panne D, Maniatis T and Harrison SC (2007) An atomic model of the interferon -
beta Enhanceosome. Cell 129, 1111-1123.
Palombella VJ and Maniatis T (1992) Inducible processing of interferon
regulatory factor-2. Mol Cell Biol. 12(8): 3325-36.
Passioura T, Shen S, Symonds G and Dolnikov A (2005) A retroviral library
genetic screen identifies IRF-2 as an inhibitor of N-ras-induced growth
suppression in leukemic cells. Oncogene. 24(49): 7327-36.
Pelletier H, and Sawaya MR (1996) Characteization of the metal ion binding
helix-hairpin-helix motifs in human DNA polymerase ~ complexed with DNA:
implications for catalytic mechanism, processivity and fidelity. Biochemistry. 35:
12742-12761.
Penninger JM, Sirard C, Mittrucker HW, Hakem A, Kimura T, Taniguchi T and
Mak TW ( 1997) the IRF-1 controls positive and negative selection of CDS+
thymocytes. Immunity, 7: 243-254.
118
REFRENCES
Pine R, Canova A and Schindler C ( 1994) Tyrosine phosphorylated p91 binds to
a single element in the ISGF2/IRF-1 promoter to mediate induction by IFNa and
IFNy, and is likely to autoregulate the p91 gene. EMBO J., 13:158-67
PineR (2002) IRF and tuberculosis. J.l.C.R., 22: 15-25.
Politis AD, Sivo J, Driggers PH, Ozato K and Vogel SN (1992) Modulation of
ICSBP rnRNA in murine peritoneal macrophages. Induction by IFNy and down
regulation by IFN-a, dexamethasone, and protein kinase inhibitors. J. Immunol.,
148: 801-807.
Reis LFL, Harada H, Wolchok JD, Taniguchi T and Vilcek J (1992) Critical role
of common transcription factor, IRF-, in the regulation of IFN and IFN -inducible
genes. EMBO 1.,11, 185-193.
Reis LF, Ruffner G, Stark G, Aguet M and Weissmann C (1994) Mice devoid of
IRF-1 show normal expression of type I IFN genes. EMBO J., 13, 4798-4806.
Richardson RJ, Dixon J, Malhotra S, Hardman MJ, Knowles L, Boot-Handford
RP, Shore P, Withmarsh A and Dixon MJ (2006) IRF-6 is a key determinant of
the keratinocytes proliferation -differentiation switch. Nat. Genet., 38: 1329-1334.
Rivas C, Thlick AE, Parravicini C, Moore PS and Chang Y (2001) Kaposi's
sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein
that inhibits p53. J. Viral., 75:429-438
Ronco LV, Karpova AY, Vidal M and Howley PM (1998) Human papillomavirus
16 E6 oncoprotein binds to IRF-3 and inhibits its transcriptional activity. Genes
Dev. 12: 2061-2072
Rouyez MC, Lestingi M, Charon M, Fichelson S, Buzyn A and Dusanter-Fourt I.
119
REFRENCES
(2005) IFN regulatory factor-2 cooperates with STATl to regulate transporter
associated with antigen processing-! promoter activity. J Immunol. 174(7): 3948-
58.
Rubinstein YR, Driggers PH, Ogryzko VV, Thornton AM, Ozato K, Pontzer
CH. (2000). Mar.An IFN regulatory factor-2 DNA-binding domain dominant
negative mutant exhibits altered cell growth and gene expression. Oncogene.
19(11): 1411-8.
Salkowski CA, Kopydlowski K, Blanco J, Cody MJ, McNally R, Vogel SN.
(1999). Aug.IL-12 is dysregulated in macrophages from IRF-1 and IRF-2
knockout mice. J Immunol. 163(3): 1529-36.
Saura M, Zaragoza C, Bao C, McMillan A and Lowenstein CJ (1999)
Interaction of IRF-1 and NFKB during inducible nitric oxide synthase
transcription. J. Mol. Bioi., 289: 459-471.
Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T,
Katsuki M, Noguchi S, Tanaka N and Taniguchi T (2000) Distinct and
essential roles of transcription factors IRF-3 and IRF-7 in response to viruses
for IFN-alpha!beta gene induction. Immunity, 13, 539-548.
Schafer SL, Lin RT, Moore PA, Hiscott J, Pitha PM 1998 Regulation of type I
interferon gene expression by interferon regulatory factor-3. Journal of biological
chemistry 273 (5): 2714-2720.
Samuel CE (2007) Interferons, interferon receptors, signal transducers and
activators of transcription, and interferon regulatory factors. J Bioi Chern. 14;
[Epub ahead of print]
Senger K, Merika M, Agalioti T, Yie J, Escalante CR, ChenG, Aggarwal AK and
Thanos D (2000) Gene repression by coactivator repulsion. Mol Cell., 6( 4):931-7.
120
REFRENCES
Shalf R, Azreil A, Lejbkowicz F, Winograd SS, Ehrlich R and Levi BZ (1995)
Functional domain analysis of ICSBP and its association with IRFs. J.Biol. Chern.,
270: 13063-13069.
Shalf R, Meraro D, Azriel A, thornton AM, Ozato K, Petricoin EF, Lamer AC,
Schaper F, Hauser H and Levi BZ (1997) Phopshorylation events modulate the
ability of ICSBP to interact with IRFs and to bind DNA. J. Bioi. Chern., 272:
9785-9792.
Schaper F, Kirchoff S, Posem G, Koster M, Oumard A, Scharf R, Levi BZ and
Hauser H (1998) Functional domains of IRF-1. Biochern. J., 335: 147-157.
Sherry B. (2002). The role of interferon regulatory factors in the cardiac response
to viral infection. Viral Immunol. 15(1):17-28. Review.
Stark GR, Kerr IM, Williams BRG, Silvermann RH and Schreiber RD (1998)
How cells respond to IFNs. Ann.Rev.Biochern. 67: 227--264.
Staal A, Enserink JM, Stein JL, Stein GS, van Wijnen AJ (2000) Molecular
characterization of celtix -1, a bromodomain protein interacting with the
transcription factor interferon regulatory factor 2. J. Cell Physiol. 185(2): 269-79.
Tailor P, Tamura T and Ozato K (2006) IRF family proteins and type I IFN
induction in dendritic cells. Cell Res., 16: 134-140.
Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, Suzuki G, Mitsuyama
M, Shin EH, Kojima S, Taniguchi T and Asano Y (1997) Multistage regulation of
Th1-type immune responses by the transcription factor IRF-1. Immunity 6:673-79
Taki S. (2002). Type I interferons and autoimmunity: lessons from the clinic and
from IRF-2-deficient mice. Cytokine Growth Factor Rev. 13(4-5):379-91.
Taki S, Nakajima S, Ichikawa E, Saito T and Hida S (2005) IFN regulatory
Factor-2 deficiency revealed a novel check point critical for the generation of
peripheral NK cells. J. Immunol, 174,6005-6012.
121
REFRENCES
Tamura T and Ozato K (2002) ICSBP/IRF-8: its regulatory roles in the
development of myeloid cells. 1./. C.R., 22: 145-152.
Tamura T, Tailor P, Yamaoka K, Kong HJ, Tsujimura H, O'Shea JJ, Singh Hand
Ozato K (2005) IFN regulatory factor-4 and -8 govern dendritic cell subset
development and their functional diversity. J. Immunol., 174, 2573-2581.
Takaoka A, Mitani Y, Suemori H, Sato M, Yokochi T, Noguchi S, Tanaka Nand
Taniguchi T (2000) Cross talk between IFN-y and -a/~ signaling components in
caveolar membrane domains. Science 288: 2357-60.
Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda
K, Ohba Y, Mak TW and Taniguchi T (2005) Integral role of IRF-5 in the gene
induction programme activated by Toll-Like receptors. Nature, 434: 243-249.
Tanaka K, Miyamoto H, Harada H, Ishihara M. and Taniguchi, T (1993)
Recognition DNA sequence of IFN Regulatory Factor -1(1RF-1) and IRF-2,
regulator of cell growth and the IFN system. Mol. Cell.Biol.13: 4531-4538.
Tanaka N, Ishihara M and Taniguchi T (1994) Suppression of c-myc or fos-B
induced cell transformation by the transcription factor IRF-1. Cancer Lett.,
83:191-196
Taniguchi T (1988) Regulation of cytokine gene expression. Annu. Rev. lmmunol.,
6: 439-464.
Taniguchi, T. (1989) Regulation of interferon-beta gene: structure and function of
cis-elements and trans-acting factors. J Interferon Res. 9(6): 633-640. Review.
Taniguchi T (1995) Cytokine signaling through non receptor protein tyrosine
kinases. Science, 268: 251-55.
1??
REFRENCES
Taniguchi T, Tanaka N, Ogasawara K, Taki S, Sato M, Takaoka A (2000)
Transcription factor IRF-1 and its family members in the regulation of host
defense. Cold Spring Harb Symp Quant Bioi. 64:465-72. Review.
Taniguchi, T., Ogasawara, K., Takaoka, A., and Tanaka, N. (2001) IRF family of
transcription factors as regulators of host defense. Annu Rev Immunol. 19: 623-
655. Review.
Thanos D and Maniatis T (1995) Virus induction of human IFN~ gene requires
the assembly of an enhanceosome. Cell, 83: 1091-1100.
Thayer MM, Aheren H, Xing D, Cunningham RP and Tainer JA (1995) Novel
DNA binding motifs in the DNA repair enzyme endonuclease III crystal structure.
EMBO J., 14:4108-4120.
Toh H, Hayashida H and Miyata T (1983) Sequence homology between
retroviral reverse Transcriptase and putative polymerases of hepatitis B virus
ans Cauliflower mosaic virus. Nature, 305: 827-829.
Vander Fits L, van der WeiLl, Laman JD, Prens EP and Verschuren MC. (2003}.
Psoriatic lesional skin exhibits an aberrant expression pattern of interferon
regulatory factor-2 (IRF-2). J Pathol. 199(1): 107-14.
Vaughan PS, Aziz F, van Wijnen AJ, Wu S, Harada H, Taniguchi T, Soprano KJ,
Stein JL and Stein GS (1995) Activation of a cell-cycle-regulated histone gene
by the oncogenic transcription factor IRF-2. Nature. 377(6547): 362-5
Vaughan PS, Meijden CM., Aziz F., Harada H., Taniguchi T., van Wijnen AJ,
Stein JL and Stein GS (1998) Cell cycle regulation of histone H4 gene
transcription requires the oncogenic factor IRF-2. J.Biol Chern. 273(1): 194-199.
123
REFRENCES
Veals C, schindler, Leonard D, Fu XY, Aebersold and Darnell JE Jr. (1992)
Subunit of an alpha-interferon-responsive transcription factor is related to IRF nad
Myb families of DNA-binding proteins. Mol. Cell. Boil., 12: 3315-3324.
Walker J, Crowley P, Moreman AD and Barrett J (1993) Biochemical properties
of cloned glutathione S-transferase from Schistosoma mansoni and Schistosoma
japonicum. Mol. Biochem. Parasitol., 61: 255-264
Wang IM, Blanco JC, Tsai SY, Tsai MJ and Ozato K (1996) Interferon regulatory
factors and TFIIB cooperatively regulate interferon-responsive promoter activity
in vivo and in vitro. Mol Cell Bioi. 16(11): 6313-24.
Wang TN, Chu YT, Chen WY, Feng WW, Shih NH, Hsiang CHand Ko YC
(2006) Association of IFNy and IRF-1 polymorphisms with asthma in a family
based association study in Taiwan. Clin. Exp. Allergy., 36: 1147-1152.
Watanabe N, Sakakibara J, Hovanessian A, Taniguchi T and Fujita T (1991)
Activation of IFN-~ promoter element by IRF-1 requires a post-translational event
in addition to IRF-1 synthesis. Nucleic Acid Res. 16:4421-28
Weaver BK, Kumar KP and Reich NC (1998) IRF-3 and CREB-binding
proteinlp300 are subunits of ds RNA activated transcription factor DRAFl. Mol.
Cell. Bioi., 18: 1359-68.
White LC, Wright KL, Felix NJ, Ruffner H, Reis LFL, Pine R and Ting JP-Y
(1996) Regulation of LMP2 and T AP1 genes by IRF-1 explains the paucity of
CD8 T cells in IRF-1 mice. Immunity 5:247-53
Willman CL, Sever CE, Pallavicini MG, Harada H, Tanaka N, Slovak ML,
Yamamoto H, Harada K, Meeker TC et. al., (1993) Deletion of IRF-1, mapping
to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.
Science, 259: 968-971.
124
REFRENCES
Xi H and Blanck G. (2000). Interferon regulatory factor-2 point mutations in
human pancreatic tumors. Int J Cancer. 87(6): 803-8.
Xie R, van Wijnen AJ, van Der Meijden C, Luong MX, Stein JL and Stein GS
(2001) The cell cycle control element of histone H4 gene transcription is
maximally responsive to interferon regulatory factor pairs IRF-1/IRF-3 and IRF-
1/IRF-7. J Bioi Chem., 276(21): 18624-32.
Xi H, Blanck G. (2003). The IRF-2 DNA binding domain facilitates the activation
of the class II transactivator (CIITA) type IV promoter by IRF-1. Mol Immunol.
39(11): 677-84.
Xi H, Eason DD, Ghosh D, Dovhey S, Wright KL and Blanck G.(1999). Co
occupancy of the interferon regulatory element of the class II transactivator
(CIITA) type IV promoter by interferon regulatory factors 1 and 2.0ncogene.
18(43): 5889-903.
Xi H, Goodwin B, Shepherd AT and Blanck G. (2001). Impaired class II
transactivator expression in mice lacking interferon regulatory factor-2.
Oncogene. 20(31): 4219-27.
Xie RL, van Wijnen AJ, van der Meijden CM, Stein JL and Stein GS. (2002).
Forced expression of the interferon regulatory factor 2 oncoprotein causes
polyploidy and cell death in FDC-P1 myeloid hematopoietic progenitor cells.
Cancer Res. 62(9): 2510-5.
Yamamoto, H.,Lauphier, M, S., Taniguchi, T. and Harada, H.(1994) . The
oncogenic transcription factor IRF-2 posses a transcriptional repression and a
activation domain. Oncogene. 9: 1423-1428.
Yan H, Krishnan K, Greenlund AC, Gupta S, Lim JT, Schrieber RD, Schindler
CW and Krolewski JJ (1996) Phosphorylated IFN-a receptor 1 subunit acts as a
125
REFRENCES
docking site for the latent form of the 113 kDa STAT2 protein. EMBO J., 15:
1064-74
Yee AA, Yin P, Siderovski DP, Mak TW, Litchfield DW and Arrowsmith CH
(1998) Cooperative interaction between the DNA binding domains of PU.1 and
IRF-4. J.Mol. Bioi., 279: 1075-1083.
Yim JH, Wu SJ, Lowney JK, Vander Velde TL and Doherty GM. (1999).
Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon
regulatory factor-2: resistance to endogenous IFN-gamma. J Interferon Cytokine
Res. 19(7): 723-9.
Yoshida K, Yamamoto T, Kohno T, Hironaka N, Yasui K, Kojima C, Mukae H,
Kadota J, Suzuki S, Honma K, Kohno S and Matsuyama T (2005) Active
repression of IRF-1 mediated transactivation by IRF-4. Int. Immunol., 17: 1463-
1471.
Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E and Fujita T(1998)
Direct triggering of the type I IFN system by virus infection: activation of
transcription factor complex containing IRF-3 and CBP/p300. EMBO J., 17:
1087-1095.
Zhang L and Pagano JS (1997) A new interferon regulatory factor associated with
Epstein- Barr virus latency. Mol. Cell. Biol. 17: 5748-57
Zhang S, Thomas K, Blanco JC, Salkowski CA and Vogel SN. (2002). The role of
the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced
cyclooxygenase-2 (COX-2) expression in vivo and in vitro. J Endotoxin Res. 8(5):
379-388.
Zhou Y, Wang S, Gobi A and Oberg K. (2000). The interferon-alpha regulation of
interferon regulatory factor 1 (IRF-1) and IRF-2 has therapeutic implications in
carcinoid tumors. Ann Oncol. 11(6): 707-14.